Profarma Distribuidora de Produtos Farmacêuticos S.A. Stock
Stocks
PFRM3
BRPFRMACNOR1
Pharmaceuticals
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.250 BRL | -8.09% |
|
-7.68% | -31.54% |
| Market Cap | 766M 151M 133M 123M 113M 213M 14.58B 216M 1.47B 571M 7.15B 567M 555M 24.73B | P/E 2024 |
6.95x | P/E 2025 | 9.42x |
|---|---|---|---|---|---|
| Enterprise Value | 1.93B 381M 334M 311M 286M 537M 36.78B 546M 3.7B 1.44B 18.03B 1.43B 1.4B 62.38B | EV / Sales 2024 |
0.18x | EV / Sales 2025 | 0.2x |
| Free-Float |
32.86% | Yield 2024 |
8.86% | Yield 2025 | - |
| 1 day | -8.09% | ||
| 1 week | -7.68% | ||
| Current month | -8.09% | ||
| 1 month | -2.65% | ||
| 3 months | -21.88% | ||
| 6 months | -28.73% | ||
| Current year | -31.54% |
| 1 week | 6.11 |  | 6.95 |
| 1 month | 6.11 | | 6.97 |
| Current year | 6.11 | | 9.7 |
| 1 year | 6.11 | | 9.7 |
| 3 years | 3.4 | | 9.7 |
| 5 years | 2.92 | | 9.7 |
| 10 years | 2.87 | | 11.79 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sammy Birmarcker
CEO | Chief Executive Officer | 57 | 2010-04-20 |
| Director of Finance/CFO | 68 | 1992-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Sammy Birmarcker
CHM | Chairman | 57 | 2008-04-02 |
| Director/Board Member | 91 | 2010-04-20 | |
| Director/Board Member | 62 | 2010-04-20 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 8/8/25 | Others | 1 | 0.0000% | |||
| 12/9/24 | Sell | 12,200 | 0.0099% | |||
| 12/9/24 | Sell | 12,400 | 0.0100% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -8.09% | -7.68% | -19.77% | +60.67% | 151M | |
| +1.99% | -0.06% | +18.40% | +103.52% | 98.45B | |
| +0.91% | -0.21% | +44.07% | +145.06% | 53.41B | |
| -1.05% | -3.07% | -0.70% | +250.62% | 22.84B | |
| -1.27% | -1.38% | -14.55% | -19.35% | 8.13B | |
| -5.96% | -5.05% | -33.58% | -35.62% | 7.4B | |
| -0.53% | -4.15% | -13.02% | -29.09% | 6.7B | |
| -0.80% | -1.73% | +19.59% | +28.57% | 6.17B | |
| -0.52% | -2.75% | -1.98% | +21.60% | 5.29B | |
| -0.99% | -1.96% | -8.24% | -9.25% | 3.69B | |
| Average | -1.63% | -3.57% | -0.98% | +51.67% | 21.22B | |
| Weighted average by Cap. | +0.71% | -1.40% | +17.77% | +109.85% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 10.15B 2B 1.76B 1.64B 1.5B 2.82B 193B 2.87B 19.43B 7.57B 94.69B 7.51B 7.35B 328B | 11.45B 2.26B 1.98B 1.84B 1.69B 3.18B 218B 3.23B 21.91B 8.54B 107B 8.47B 8.29B 370B |
| Net income | 115M 22.58M 19.82M 18.46M 16.95M 31.82M 2.18B 32.35M 219M 85.43M 1.07B 84.75M 82.92M 3.7B | 119M 23.43M 20.56M 19.16M 17.59M 33.02M 2.26B 33.57M 228M 88.65M 1.11B 87.94M 86.05M 3.84B |
| Net Debt | 1.02B 200M 176M 164M 150M 283M 19.35B 287M 1.95B 758M 9.49B 752M 736M 32.83B | 1.17B 230M 202M 188M 173M 324M 22.2B 329M 2.23B 870M 10.88B 863M 844M 37.65B |
Employees
7,077
Sector
Pharmaceuticals
Calendar
Jul. 28
Earnings release - Q2 2026
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-24 | R$6.250 | +0.48% | 214,200 |
| 26-07-23 | R$6.220 | -6.47% | 112,800 |
| 26-07-22 | R$6.650 | -1.63% | 182,600 |
| 26-07-21 | R$6.760 | -1.31% | 135,700 |
| 26-07-20 | R$6.850 | +1.18% | 46,300 |
- Stock Market
- Stocks
- PFRM3 Stock
Select your edition
All financial news and data tailored to specific country editions
